Year |
Citation |
Score |
2023 |
Wong SJ, Torres-Saavedra PA, Saba NF, Shenouda G, Bumpous JM, Wallace RE, Chung CH, El-Naggar AK, Gwede CK, Burtness B, Tennant PA, Dunlap NE, Redman R, Stokes WA, Rudra S, ... ... Contessa JN, et al. Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus Head and Neck Carcinoma: A Phase 2 Randomized Clinical Trial. Jama Oncology. PMID 37768670 DOI: 10.1001/jamaoncol.2023.3809 |
0.35 |
|
2021 |
Petrulli JR, Zheng M, Huang Y, Nabulsi NB, Goldberg SB, Contessa JN, Morris ED. Evaluation of quantitative modeling methods in whole-body, dynamic [C]-erlotinib PET. American Journal of Nuclear Medicine and Molecular Imaging. 11: 143-153. PMID 34079641 |
0.318 |
|
2019 |
Baro M, Lopez Sambrooks C, Burtness BA, Lemmon MA, Contessa JN. Neuregulin Signaling is a Mechanism of Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics. PMID 31387891 DOI: 10.1158/1535-7163.Mct-19-0163 |
0.374 |
|
2019 |
Klaver E, Zhao P, May M, Flanagan-Steet H, Freeze HH, Gilmore R, Wells L, Contessa J, Steet R. Selective inhibition of N-linked glycosylation impairs receptor tyrosine kinase processing. Disease Models & Mechanisms. PMID 31101650 DOI: 10.1242/Dmm.039602 |
0.37 |
|
2018 |
Lopez Sambrooks C, Baro M, Quijano A, Narayan A, Wei C, Greninger P, Egan RK, Patel AA, Benes CH, Saltzman WM, Contessa JN. Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors. Cancer Research. PMID 30026325 DOI: 10.1158/0008-5472.Can-18-0505 |
0.453 |
|
2018 |
Baro M, Lopez Sambrooks C, Quijano A, Saltzman WM, Contessa JN. Oligosaccharyltransferase inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29967251 DOI: 10.1158/1078-0432.Ccr-18-0792 |
0.411 |
|
2017 |
Petrulli JR, Hansen SB, Abourbeh G, Yaqub M, Bahce I, Holden D, Huang Y, Nabulsi NB, Contessa JN, Mishani E, Lammertsma AA, Morris ED. A multi species evaluation of the radiation dosimetry of [(11)C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor. Nuclear Medicine and Biology. 47: 56-61. PMID 28126682 DOI: 10.1016/J.Nucmedbio.2016.12.009 |
0.424 |
|
2017 |
Magnuson WJ, Lester-Coll NH, Wu AJ, Yang TJ, Lockney NA, Gerber NK, Beal K, Amini A, Patil T, Kavanagh BD, Camidge DR, Braunstein SE, Boreta LC, Balasubramanian SK, Ahluwalia MS, ... ... Contessa JN, et al. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016697144. PMID 28113019 DOI: 10.1200/JCO.2016.69.7144 |
0.374 |
|
2016 |
Lopez-Sambrooks C, Shrimal S, Khodier C, Flaherty DP, Rinis N, Charest JC, Gao N, Zhao P, Wells L, Lewis TA, Lehrman MA, Gilmore R, Golden JE, Contessa JN. Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells. Nature Chemical Biology. PMID 27694802 DOI: 10.1038/Nchembio.2194 |
0.425 |
|
2016 |
Magnuson WJ, Amini A, Patil T, Kavanagh BD, Camidge DR, Braunstein SE, Boreta L, Attia A, Rana N, Contessa JN, Gettinger SN, Lester-Coll NH, Yu JB, Chiang VL. Deferring Radiation Therapy for Brain Metastases in Patients With EGFR-Mutant Non-Small Cell Lung Cancer: A Multi-Institutional Analysis. International Journal of Radiation Oncology, Biology, Physics. 96: S57-S58. PMID 27675963 DOI: 10.1016/j.ijrobp.2016.06.149 |
0.306 |
|
2014 |
Cazet A, Charest J, Bennett DC, Sambrooks CL, Contessa JN. Mannose phosphate isomerase regulates fibroblast growth factor receptor family signaling and glioma radiosensitivity. Plos One. 9: e110345. PMID 25314669 DOI: 10.1371/journal.pone.0110345 |
0.438 |
|
2013 |
Petrulli JR, Sullivan JM, Zheng MQ, Bennett DC, Charest J, Huang Y, Morris ED, Contessa JN. Quantitative analysis of [11C]-erlotinib PET demonstrates specific binding for activating mutations of the EGFR kinase domain. Neoplasia (New York, N.Y.). 15: 1347-53. PMID 24403856 DOI: 10.1593/Neo.131666 |
0.395 |
|
2013 |
Bennett DC, Charest J, Sebolt K, Lehrman M, Rehemtulla A, Contessa JN. High-throughput screening identifies aclacinomycin as a radiosensitizer of EGFR-mutant non-small cell lung cancer. Translational Oncology. 6: 382-91. PMID 23730419 DOI: 10.1593/tlo.13232 |
0.359 |
|
2011 |
Khan AP, Contessa JN, Nyati MK, Ross BD, Rehemtulla A. Molecular imaging of epidermal growth factor receptor kinase activity. Analytical Biochemistry. 417: 57-64. PMID 21693098 DOI: 10.1016/j.ab.2011.05.040 |
0.524 |
|
2010 |
Contessa JN, Bhojani MS, Freeze HH, Ross BD, Rehemtulla A, Lawrence TS. Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 3205-14. PMID 20413434 DOI: 10.1158/1078-0432.CCR-09-3331 |
0.413 |
|
2008 |
Contessa JN, Bhojani MS, Freeze HH, Rehemtulla A, Lawrence TS. Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells. Cancer Research. 68: 3803-9. PMID 18483264 DOI: 10.1158/0008-5472.CAN-07-6389 |
0.414 |
|
2008 |
Contessa JN, Hamstra DA. Revoking the privilege: targeting HER2 in the central nervous system. Molecular Pharmacology. 73: 271-3. PMID 17981994 DOI: 10.1124/mol.107.042986 |
0.341 |
|
2006 |
Contessa JN, Abell A, Valerie K, Lin PS, Schmidt-Ullrich RK. ErbB receptor tyrosine kinase network inhibition radiosensitizes carcinoma cells. International Journal of Radiation Oncology, Biology, Physics. 65: 851-8. PMID 16751066 DOI: 10.1016/J.Ijrobp.2006.02.025 |
0.713 |
|
2006 |
Contessa JN, Abell A, Mikkelsen RB, Valerie K, Schmidt-Ullrich RK. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation. Breast Cancer Research and Treatment. 95: 17-27. PMID 16267617 DOI: 10.1007/S10549-005-9023-9 |
0.689 |
|
2003 |
Lammering G, Hewit TH, Valerie K, Lin PS, Contessa JN, Schmidt-Ullrich RK. Anti-erbB receptor strategy as a gene therapeutic intervention to improve radiotherapy in malignant human tumours. International Journal of Radiation Biology. 79: 561-8. PMID 14530165 DOI: 10.1080/0955300031000102632 |
0.606 |
|
2003 |
Schmidt-Ullrich RK, Contessa JN, Lammering G, Amorino G, Lin PS. ERBB receptor tyrosine kinases and cellular radiation responses. Oncogene. 22: 5855-65. PMID 12947392 DOI: 10.1038/Sj.Onc.1206698 |
0.717 |
|
2003 |
Lammering G, Hewit TH, Valerie K, Contessa JN, Amorino GP, Dent P, Schmidt-Ullrich RK. EGFRvIII-mediated radioresistance through a strong cytoprotective response. Oncogene. 22: 5545-53. PMID 12944901 DOI: 10.1038/Sj.Onc.1206788 |
0.733 |
|
2003 |
Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, Hagan MP, Grant S, Schmidt-Ullrich R. Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiation Research. 159: 283-300. PMID 12600231 DOI: 10.1667/0033-7587(2003)159[0283:Sariao]2.0.Co;2 |
0.646 |
|
2002 |
Contessa JN, Hampton J, Lammering G, Mikkelsen RB, Dent P, Valerie K, Schmidt-Ullrich RK. Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells. Oncogene. 21: 4032-41. PMID 12037685 DOI: 10.1038/Sj.Onc.1205500 |
0.67 |
|
2002 |
Contessa J, Abell A, Lammering G, Hewit T, Valerie K, Schmidt-Ullrich R. EGRF-CD533 acts as a PAN-ERBB receptor tyrosine kinase inhibitor International Journal of Radiation Oncology*Biology*Physics. 54: 175-176. DOI: 10.1016/S0360-3016(02)03361-8 |
0.646 |
|
2001 |
Lammering G, Lin PS, Contessa JN, Hampton JL, Valerie K, Schmidt-Ullrich RK. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells. International Journal of Radiation Oncology, Biology, Physics. 51: 775-84. PMID 11697324 DOI: 10.1016/S0360-3016(01)01714-X |
0.723 |
|
2001 |
Lammering G, Hewit TH, Hawkins WT, Contessa JN, Reardon DB, Lin PS, Valerie K, Dent P, Mikkelsen RB, Schmidt-Ullrich RK. Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization. Journal of the National Cancer Institute. 93: 921-9. PMID 11416113 DOI: 10.1093/Jnci/93.12.921 |
0.718 |
|
2001 |
Lammering G, Valerie K, Lin PS, Mikkelsen RB, Contessa JN, Feden JP, Farnsworth J, Dent P, Schmidt-Ullrich RK. Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 682-90. PMID 11297265 |
0.717 |
|
2001 |
Lammering G, Hewit T, Contessa J, Hawkins W, Lin P, Valerie K, Mikkelsen R, Dent P, Schmidt-Ullrich R. EGFR and its mutant EGFRvIII as modulators of tumor cell radiosensitivity International Journal of Radiation Oncology*Biology*Physics. 51: 103. DOI: 10.1016/S0360-3016(01)02012-0 |
0.696 |
|
1999 |
Schmidt-Ullrich RK, Contessa JN, Dent P, Mikkelsen RB, Valerie K, Reardon DB, Bowers G, Lin PS. Molecular mechanisms of radiation-induced accelerated repopulation. Radiation Oncology Investigations. 7: 321-30. PMID 10644055 DOI: 10.1002/(Sici)1520-6823(1999)7:6<321::Aid-Roi2>3.0.Co;2-Q |
0.519 |
|
1999 |
Reardon DB, Contessa JN, Mikkelsen RB, Valerie K, Amir C, Dent P, Schmidt-Ullrich RK. Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene. 18: 4756-66. PMID 10467423 DOI: 10.1038/Sj.Onc.1202849 |
0.74 |
|
1999 |
Contessa JN, Reardon DB, Todd D, Dent P, Mikkelsen RB, Valerie K, Bowers GD, Schmidt-Ullrich RK. The inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in radiosensitization of human mammary carcinoma cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 5: 405-11. PMID 10037190 |
0.74 |
|
1999 |
Schmidt-ullrich R, Bowers G, Dent P, Reardon D, Contessa J, Valerie K. 29 ERBB receptor tyrosine kinases as determinants of cytoprotective and cytotoxic radiation responses of carcinoma cells International Journal of Radiation Oncology*Biology*Physics. 45: 161-162. DOI: 10.1016/S0360-3016(99)90047-0 |
0.696 |
|
1998 |
Auer KL, Contessa J, Brenz-Verca S, Pirola L, Rusconi S, Cooper G, Abo A, Wymann MP, Davis RJ, Birrer M, Dent P. The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes. Molecular Biology of the Cell. 9: 561-73. PMID 9487126 DOI: 10.1091/Mbc.9.3.561 |
0.355 |
|
1997 |
Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, Contessa JN, Rorrer WK, Chen PB. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene. 15: 1191-7. PMID 9294612 DOI: 10.1038/Sj.Onc.1201275 |
0.704 |
|
1996 |
Schmidt-Ullrich R, Mikkelsen R, Valerie K, Todd D, Kavanagh B, Contessa J, Rorrer K, Chen P. 134 Molecular mechanisms of radiation-induced cell proliferation in human carcinoma cells International Journal of Radiation Oncology*Biology*Physics. 36: 225. DOI: 10.1016/S0360-3016(97)85475-2 |
0.607 |
|
Low-probability matches (unlikely to be authored by this person) |
2012 |
Johung K, Yu J, Gettinger S, Decker R, Hess J, Chiang V, Contessa J. The Radiosensitivity of Tyrosine Kinase Driven Non-small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S115. DOI: 10.1016/J.Ijrobp.2012.07.201 |
0.298 |
|
2021 |
Lu BY, Gupta R, Aguirre-Ducler A, Gianino N, Wyatt H, Ribeiro M, Chiang VL, Contessa JN, Adeniran AJ, Jilaveanu LB, Kluger HM, Schalper KA, Goldberg SB. Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastases. Journal For Immunotherapy of Cancer. 9. PMID 34670827 DOI: 10.1136/jitc-2021-002684 |
0.261 |
|
2018 |
Bristow RG, Alexander B, Baumann M, Bratman SV, Brown JM, Camphausen K, Choyke P, Citrin D, Contessa JN, Dicker A, Kirsch DG, Krause M, Le QT, Milosevic M, Morris ZS, et al. Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology. The Lancet. Oncology. 19: e240-e251. PMID 29726389 DOI: 10.1016/S1470-2045(18)30096-2 |
0.251 |
|
2013 |
Johung KL, Yao X, Li F, Yu JB, Gettinger SN, Goldberg S, Decker RH, Hess JA, Chiang VL, Contessa JN. A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5523-32. PMID 23897899 DOI: 10.1158/1078-0432.Ccr-13-0836 |
0.248 |
|
2023 |
Draeger E, Roberts K, Decker RD, Bahar N, Wilson LD, Contessa J, Husain Z, Williams BB, Flood AB, Swartz HM, Carlson DJ. In vivo verification of electron paramagnetic resonance biodosimetry using patients undergoing radiotherapy treatment. International Journal of Radiation Oncology, Biology, Physics. PMID 38072322 DOI: 10.1016/j.ijrobp.2023.11.029 |
0.238 |
|
2020 |
Liu Y, Awadia S, Delaney A, Sitto M, Engelke C, Patel H, Calcaterra A, Zelenka-Wang S, Lee H, Contessa J, Neamati N, Ljungman M, Lawrence TS, Morgan MA, Rehemtulla A. UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancer. Translational Oncology. 13: 100834. PMID 32688248 DOI: 10.1016/J.Tranon.2020.100834 |
0.232 |
|
2022 |
Wandrey NE, Gao D, Robin TP, Contessa JN, Singh C, Chiang V, Li J, Chen A, Wang Y, Sheehan JP, Dutta SW, Weiss SE, Paly J, Rusthoven CG. Multicenter analysis of stereotactic radiosurgery for multiple brain metastases from EGFR and ALK driven non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 176: 144-148. PMID 36641932 DOI: 10.1016/j.lungcan.2022.11.019 |
0.232 |
|
2012 |
Yoon W, Kim J, Han Y, Chung D, Park Y, Lizarraga KJ, Allen-Auerbach M, De Salles AA, Yong WH, Chen W, Ruge MI, Kickingereder P, Simon T, Treuer H, Sturm V, ... ... Contessa JN, et al. CLIN-RADIATION THERAPY Neuro-Oncology. 14: vi133-vi141. DOI: 10.1093/Neuonc/Nos238 |
0.231 |
|
2018 |
Bennett DC, Cazet A, Charest J, Contessa JN. MPDU1 regulates CEACAM1 and cell adhesion in vitro and in vivo. Glycoconjugate Journal. PMID 29671116 DOI: 10.1007/s10719-018-9819-6 |
0.229 |
|
2016 |
An Y, Park HS, Kelly JR, Stahl JM, Contessa JN, Husain ZA. The Prognostic Importance of Pathologic Extracapsular Extension in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. International Journal of Radiation Oncology, Biology, Physics. 96: E346. PMID 27674439 DOI: 10.1016/j.ijrobp.2016.06.1500 |
0.226 |
|
2021 |
Hayman TJ, Baro M, MacNeil T, Phoomak C, Aung TN, Cui W, Leach K, Iyer R, Challa S, Sandoval-Schaefer T, Burtness BA, Rimm DL, Contessa JN. STING enhances cell death through regulation of reactive oxygen species and DNA damage. Nature Communications. 12: 2327. PMID 33875663 DOI: 10.1038/s41467-021-22572-8 |
0.223 |
|
2013 |
Motwani S, Contessa J, Corso C, Jain P, Modh A, Wang S, Khan A, Knisely J. Glioblastoma Multiforme of the Elderly: A Multi-institutional Experience Comparing Conventional Versus Accelerated Radiation Therapy With Concurrent Temozolomide International Journal of Radiation Oncology*Biology*Physics. 87: S252-S253. DOI: 10.1016/j.ijrobp.2013.06.657 |
0.218 |
|
2016 |
Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, ... ... Contessa J, et al. The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases. International Journal of Radiation Oncology, Biology, Physics. 96: 406-413. PMID 27598807 DOI: 10.1016/J.Ijrobp.2016.06.006 |
0.214 |
|
2018 |
Rinis N, Golden JE, Marceau CD, Carette JE, Van Zandt MC, Gilmore R, Contessa JN. Editing N-Glycan Site Occupancy with Small-Molecule Oligosaccharyltransferase Inhibitors. Cell Chemical Biology. PMID 30078634 DOI: 10.1016/J.Chembiol.2018.07.005 |
0.202 |
|
2017 |
Chowdhary M, Okwan-Duodu D, Switchenko JM, Press RH, Jhaveri J, Buchwald ZS, Zhong J, Chapman BV, Bindra RS, Contessa JN, Park HS, Yu JB, Decker RH, Olson JJ, Oyesiku NM, et al. Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery. Journal of Neuro-Oncology. PMID 29124649 DOI: 10.1007/S11060-017-2652-0 |
0.196 |
|
2022 |
Wallington DG, Contessa JN, Hayman TJ. STING Agonists in Head and Neck Squamous Cell Carcinoma. Cancer Journal (Sudbury, Mass.). 28: 401-406. PMID 36165729 DOI: 10.1097/PPO.0000000000000620 |
0.193 |
|
2021 |
Fisk JN, Mahal AR, Dornburg A, Gaffney SG, Aneja S, Contessa JN, Rimm D, Yu JB, Townsend JP. Premetastatic shifts of endogenous and exogenous mutational processes support consolidative therapy in EGFR-driven lung adenocarcinoma. Cancer Letters. PMID 34780851 DOI: 10.1016/j.canlet.2021.11.011 |
0.192 |
|
2010 |
Rewari A, Wu H, Contessa J, Haffty B, Decker R. Prognostic Value of p16 Expression in Laryngeal Cancer Patients Treated with Radiation International Journal of Radiation Oncology*Biology*Physics. 78: S64. DOI: 10.1016/J.Ijrobp.2010.07.181 |
0.192 |
|
2017 |
An Y, Park HS, Kelly JR, Stahl JM, Yarbrough WG, Burtness BA, Contessa JN, Decker RH, Koshy M, Husain ZA. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cancer. PMID 28323338 DOI: 10.1002/Cncr.30598 |
0.184 |
|
2018 |
Jairam V, Kann B, Patel K, Yu J, Hansen J, Husain Z, Bindra R, Contessa J, Omay S, Chiang V, Park H. Evolving National Practice Patterns of Hypofractionated Stereotactic Radiation Therapy Versus Single-Fraction Radiosurgery for Brain Metastases International Journal of Radiation Oncology*Biology*Physics. 102: e227. DOI: 10.1016/J.Ijrobp.2018.07.775 |
0.182 |
|
2015 |
Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Ning MS, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD, Chiang VL, Camidge DR, ... Contessa JN, et al. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26438117 DOI: 10.1200/Jco.2015.62.0138 |
0.18 |
|
2018 |
Lester-Coll NH, Supko JG, Kluytenaar J, Pavlik KF, Yu JB, Moliterno J, Piepmeier J, Becker K, Baehring JM, Huttner A, Vortmeyer A, Contessa JN, Ramani R, Lampert R, Yao X, et al. Mibefradil dihydrochoride with hypofractionated radiation for recurrent glioblastoma: A phase I dose expansion trial. Journal of Clinical Oncology. 36: e14046-e14046. DOI: 10.1200/Jco.2018.36.15_Suppl.E14046 |
0.18 |
|
2015 |
Lester-Coll NH, Kluytenaar J, Pavlik KF, Yu JB, Contessa JN, Moliterno J, Piepmeier JM, Becker KP, Baehring JM, Huttner AJ, Vortmeyer AO, Ramani R, Lampert RJ, Yao X, Bindra RS. ATNT-15MIBEFRADIL DIHYDROCHORIDE WITH HYPOFRACTIONATED RADIATION FOR RECURRENT GLIOBLASTOMA: PRELIMINARY RESULTS OF A PHASE I DOSE EXPANSION TRIAL Neuro-Oncology. 17: v13.3-v13. DOI: 10.1093/Neuonc/Nov205.15 |
0.175 |
|
2017 |
Puschnik AS, Marceau CD, Ooi YS, Majzoub K, Rinis N, Contessa JN, Carette JE. A Small-Molecule Oligosaccharyltransferase Inhibitor with Pan-flaviviral Activity. Cell Reports. 21: 3032-3039. PMID 29241533 DOI: 10.1016/j.celrep.2017.11.054 |
0.173 |
|
2019 |
Hayman T, Baro M, Cui W, Contessa J. Whole Genome CRISPR-Cas9 Screen Identifies STING as a Determinant of Intrinsic Radiosensitivity in Head and Neck Squamous Cell Carcinoma International Journal of Radiation Oncology*Biology*Physics. 105: S77-S78. DOI: 10.1016/j.ijrobp.2019.06.538 |
0.165 |
|
2016 |
Kelly JR, Park HS, An Y, Decker RH, Contessa JN, Yarbrough WG, Burtness BA, Judson BL, Husain ZA. Comparison of Upfront Surgery Versus Chemoradiation for cT1-2 N1-2b Oropharynx Squamous Cell Carcinoma Based on Human Papillomavirus Status. International Journal of Radiation Oncology, Biology, Physics. 96: E327. PMID 27674389 DOI: 10.1016/J.Ijrobp.2016.06.1451 |
0.162 |
|
2014 |
Colaco R, Martin P, Bond J, Bindra R, Contessa J, Kluger H, Yu J, Chiang V. Systemic Treatment and Radiation Necrosis Following Gamma Knife Radiosurgery in the Treatment of Brain Metastases International Journal of Radiation Oncology*Biology*Physics. 90: S310. DOI: 10.1016/J.Ijrobp.2014.05.1035 |
0.158 |
|
2018 |
Chen WS, Bindra RS, Mo A, Hayman T, Husain Z, Contessa JN, Gaffney SG, Townsend JP, Yu JB. CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology. 8: 95. PMID 29670856 DOI: 10.3389/Fonc.2018.00095 |
0.155 |
|
2006 |
Contessa JN, Roberson PL. Targeted radiation for melanoma: alpha therapy prepares for a beta test. Cancer Biology & Therapy. 5: 118-9. PMID 16491043 |
0.155 |
|
2017 |
Kelly JR, Park HS, An Y, Contessa JN, Yarbrough WG, Burtness BA, Decker R, Husain Z. Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational Study. Jama Oncology. PMID 28056116 DOI: 10.1001/Jamaoncol.2016.5769 |
0.149 |
|
2017 |
Muhlestein W, Chambless L, Pajewski N, Braunstein S, Hepel J, Chung C, Contessa J, Chao S, Fiveash J, Attia A, Chan M, Ayala-Peacock D. Using a Novel Machine Learning Technique to Predict Radiation Oncology Outcomes International Journal of Radiation Oncology*Biology*Physics. 99: E422-E423. DOI: 10.1016/J.Ijrobp.2017.06.1614 |
0.148 |
|
2016 |
Rutter CE, Johung KL, Yao X, Lu AY, Jilaveanu LB, Yu JB, Contessa JN, Kluger HM, Chiang VLS, Bindra RS. Demonstration of differential radiosensitivity based upon mutation profile in metastatic melanoma treated with stereotactic radiosurgery. Journal of Radiosurgery and Sbrt. 4: 97-106. PMID 29296434 |
0.147 |
|
2022 |
Jairam V, Park HS, Yu JB, Bindra RS, Contessa JN, Jethwa KR. Practice Patterns Related to Mitigation of Neurocognitive Decline in Patients Receiving Whole Brain Radiation Therapy. Advances in Radiation Oncology. 7: 100949. PMID 35521071 DOI: 10.1016/j.adro.2022.100949 |
0.146 |
|
2014 |
Colaco R, Martin P, Bond J, Bindra R, Contessa J, Kluger H, Yu J, Chiang V. BM-10 * SYSTEMIC TREATMENT AND RADIATION NECROSIS FOLLOWING GKSRS IN THE TREATMENT OF BRAIN METASTASES Neuro-Oncology. 16: v34-v34. DOI: 10.1093/Neuonc/Nou240.10 |
0.146 |
|
2009 |
Contessa J, Wang G, Pienta K, Chinnaiyan A, Wei J, Hamstra D, Sandler H. Serum PDGF Decreases during Combined Radiation and Androgen Deprivation Therapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 75: S305. DOI: 10.1016/J.Ijrobp.2009.07.701 |
0.145 |
|
2016 |
Lester-Coll NH, Kluytenaar J, Pavlik KF, Yu JB, Contessa JN, Moliterno J, Piepmeier J, Becker KP, Baehring J, Huttner AJ, Vortmeyer AO, Ramani R, Lampert RJ, Yao X, Bindra RS. Mibefradil Dihydrochloride With Hypofractionated Radiation for Recurrent Glioblastoma: Preliminary Results of a Phase 1 Dose Expansion Trial. International Journal of Radiation Oncology, Biology, Physics. 96: S93. PMID 27676055 DOI: 10.1016/J.Ijrobp.2016.06.233 |
0.14 |
|
2019 |
Yu JB, Singh C, Bindra RS, Contessa JN, Husain Z, Hansen JE, Park HS, Roberts KB, Bond JE, Tien CJ, Guo F, Colaco RJ, Housri N, Magnuson WJ, Mahajan A, et al. Results of a pilot/phase II study of gamma knife radiosurgery for brain metastases and implications for future prospective clinical trials Journal of Radiation Oncology. 8: 39-46. DOI: 10.1007/S13566-018-0370-7 |
0.139 |
|
2018 |
Soike M, McTyre E, Farris M, Ayala-Peacock D, Hepel J, Page B, Kleinberg L, Contessa J, Chiang V, Cramer C, Ruiz J, Pasche B, Tatter S, Fiveash J, Ahluwalia M, et al. Salvage Stereotactic Radiosurgery is Associated with Improved Overall Survival Compared to Whole Brain Radiation in the Setting of Progressive Brain Metastases International Journal of Radiation Oncology*Biology*Physics. 102: S144. DOI: 10.1016/J.Ijrobp.2018.06.350 |
0.138 |
|
2019 |
Lu H, Cherepanova NA, Gilmore R, Contessa JN, Lehrman MA. Targeting STT3A-oligosaccharyltransferase with NGI-1 causes herpes simplex virus 1 dysfunction. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201802044RR. PMID 30811219 DOI: 10.1096/Fj.201802044Rr |
0.135 |
|
2018 |
Kelly JR, Park HS, An Y, Yarbrough WG, Contessa JN, Decker R, Mehra S, Judson BL, Burtness B, Husain Z. Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer. Oral Oncology. 79: 64-70. PMID 29598952 DOI: 10.1016/J.Oraloncology.2018.02.017 |
0.134 |
|
2023 |
Phoomak C, Rinis N, Baro M, Shrimal S, Bennett D, Shaffer SA, Lehrman M, Gilmore R, Contessa JN. Signal recognition particle receptor-β (SR-β) coordinates cotranslational N-glycosylation. Science Advances. 9: eade8079. PMID 36921042 DOI: 10.1126/sciadv.ade8079 |
0.127 |
|
2013 |
Johung K, Rewari A, Wu H, Judson B, Contessa JN, Haffty BG, Decker RH. Role of excision repair cross-complementation 1 expression as a prognostic marker for response to radiotherapy in early-stage laryngeal cancer. Head & Neck. 35: 852-7. PMID 22740347 DOI: 10.1002/Hed.23041 |
0.124 |
|
2015 |
Goldberg SB, Contessa JN, Omay SB, Chiang V. Lung Cancer Brain Metastases. Cancer Journal (Sudbury, Mass.). 21: 398-403. PMID 26389765 DOI: 10.1097/PPO.0000000000000146 |
0.115 |
|
2009 |
Contessa JN, Griffith KA, Wolff E, Ensminger W, Zalupski M, Lawrence TS, Ben-Josef E. Radiotherapy for pancreatic neuroendocrine tumors. International Journal of Radiation Oncology, Biology, Physics. 75: 1196-200. PMID 19327905 DOI: 10.1016/j.ijrobp.2008.12.044 |
0.113 |
|
2016 |
McTyre E, Ayala-Peacock DN, Contessa JN, Chung C, Fiveash JB, Ahluwalia M, Kotecha R, Chao ST, Attia A, Hepel JT, Braunstein SE, Chan MD. Multi-Institutional Competing Risks Analysis Predicting Distant Brain Failure and Salvage Patterns After Upfront Radiosurgery Without Whole-Brain Radiation Therapy for Brain Metastasis. International Journal of Radiation Oncology, Biology, Physics. 96: S180-S181. PMID 27675725 DOI: 10.1016/J.Ijrobp.2016.06.452 |
0.108 |
|
2019 |
Yeboa DN, Yu JB, Liao E, Huse J, Penas-Prado M, Kann BH, Sulman E, Grosshans D, Contessa J. Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas. Clinical and Translational Radiation Oncology. 15: 46-52. PMID 30656222 DOI: 10.1016/J.Ctro.2018.12.003 |
0.106 |
|
2018 |
Lu BY, Gupta R, Ribeiro M, Stewart T, Chiang V, Contessa JN, Adeniran A, Kluger HM, Jilaveanu L, Schalper KA, Goldberg SB. PD-L1 expression and tumor-infiltrating lymphocytes in lung cancer brain metastases. Journal of Clinical Oncology. 36: e24116-e24116. DOI: 10.1200/JCO.2018.36.15_SUPPL.E24116 |
0.104 |
|
2016 |
Sperduto P, Yang TJ, Beal K, Pan H, Brown P, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle JM, Kirkpatrick J, Mak K, Shih H, ... ... Contessa J, et al. BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA) Neuro-Oncology. 18: vi27-vi27. DOI: 10.1093/Neuonc/Now212.106 |
0.103 |
|
2021 |
Phoomak C, Cui W, Hayman TJ, Yu SH, Zhao P, Wells L, Steet R, Contessa JN. The translocon-associated protein (TRAP) complex regulates quality control of N-linked glycosylation during ER stress. Science Advances. 7. PMID 33523898 DOI: 10.1126/sciadv.abc6364 |
0.097 |
|
2017 |
Chen WS, Bindra R, Mo A, Hayman T, Husain Z, Contessa JN, Gaffney SG, Townsend JP, Yu JB. CDKN2A copy number loss in HPV- and HPV+ head and neck cancer to indicate poor prognosis: An integrated genomic and clinical TCGA analysis. Journal of Clinical Oncology. 35: 6060-6060. DOI: 10.1200/Jco.2017.35.15_Suppl.6060 |
0.095 |
|
2015 |
Aneja S, Contessa J, Husain Z, Glazer P, Hansen J, Bindra R, Yu J. mRNA Expression of TP53 Attenuates Survival of HPV+ Locally Advanced Head and Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 93: E350-E351. DOI: 10.1016/J.Ijrobp.2015.07.1440 |
0.088 |
|
2016 |
Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, ... ... Contessa J, et al. Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA). Jama Oncology. PMID 27892978 DOI: 10.1001/Jamaoncol.2016.3834 |
0.085 |
|
2016 |
Colaco RJ, Yu JB, Bond JS, Bindra RS, Contessa JN, Knisely JPS, Chiang VL. A contemporary dose selection algorithm for stereotactic radiosurgery in the treatment of brain metastases - An initial report. Journal of Radiosurgery and Sbrt. 4: 43-52. PMID 29296425 |
0.083 |
|
2007 |
Spalding AC, Contessa JN. Using ErbB2-negative status to direct therapy in locally advanced breast cancer. Cancer Biology & Therapy. 6: 463-4. PMID 17471028 |
0.082 |
|
2019 |
Jairam V, Kann BH, Park HS, Miccio JA, Beckta JM, Yu JB, Prabhu RS, Gao SJ, Mehta MP, Curran WJ, Bindra RS, Contessa JN, Patel KR. Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis. Anticancer Research. 39: 2911-2918. PMID 31177129 DOI: 10.21873/Anticanres.13420 |
0.082 |
|
2021 |
Burtness B, Contessa J. Hypoxia-Guided Therapy for Human Papillomavirus-Associated Oropharynx Cancer. Journal of the National Cancer Institute. PMID 33429429 DOI: 10.1093/jnci/djaa187 |
0.081 |
|
2017 |
Yeboa DN, Rutter CE, Park HS, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Contessa J, Yu JB. Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomas. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 29054377 DOI: 10.1016/J.Radonc.2017.09.027 |
0.081 |
|
2023 |
Guay KP, Ke H, Canniff NP, George GT, Eyles SJ, Mariappan M, Contessa JN, Gershenson A, Gierasch LM, Hebert DN. ER chaperones use a protein folding and quality control glyco-code. Molecular Cell. PMID 38052210 DOI: 10.1016/j.molcel.2023.11.006 |
0.08 |
|
2019 |
Gao S, Corbin Z, Moliterno J, Bindra R, Yu JB, Park HS, Contessa J. Radiotherapy Timing Following Biopsy and Its Effect on Overall Survival in Unresected Glioblastoma Multiforme International Journal of Radiation Oncology*Biology*Physics. 103: E26. DOI: 10.1016/S0360-3016(19)30459-6 |
0.08 |
|
2022 |
Gao S, Jin L, Moliterno J, Corbin ZA, Bindra RS, Contessa JN, Yu JB, Park HS. Impact of radiotherapy delay following biopsy for patients with unresected glioblastoma. Journal of Neurosurgery. 1-11. PMID 35907197 DOI: 10.3171/2022.5.JNS212761 |
0.077 |
|
2011 |
Contessa J, Charest J, Bennett D. A High Throughput Screen for Inhibitors of RTK Post-translational Processing International Journal of Radiation Oncology*Biology*Physics. 81: S53-S54. DOI: 10.1016/j.ijrobp.2011.06.108 |
0.077 |
|
2013 |
Corso C, Bindra R, Yu J, Contessa J. Factors Predicting Survival in Grade 1-3 Astrocytomas International Journal of Radiation Oncology*Biology*Physics. 87: S253-S254. DOI: 10.1016/J.Ijrobp.2013.06.659 |
0.076 |
|
2017 |
Ayala-Peacock DN, Attia A, Braunstein SE, Ahluwalia MS, Hepel J, Chung C, Contessa J, McTyre E, Peiffer AM, Lucas JT, Isom S, Pajewski NM, Kotecha R, Stavas MJ, Page BR, et al. Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram. Journal of Neuro-Oncology. PMID 28828698 DOI: 10.1007/S11060-017-2588-4 |
0.076 |
|
2012 |
Nath S, Sheridan A, Rauch P, Contessa J, Yu J, Knisely J, Minja F, Chiang V, Vortmeyer A. TRIC or Tumor: Regrowing Lesions Following Radiosurgery for Brain Metastases — Proposal for a Histopathologic Scale Based on Correlation With Survival International Journal of Radiation Oncology*Biology*Physics. 84: S297. DOI: 10.1016/J.IJROBP.2012.07.776 |
0.075 |
|
2018 |
Yu J, Singh C, Bindra R, Contessa J, Husain Z, Hansen J, Park H, Roberts K, Bond J, Tien C, Guo F, Colaco R, Housri N, Magnuson W, Omay B, et al. A Pilot/Phase II Study of Stereotactic Radiosurgery for Brain Metastases Using Rational Dose Selection International Journal of Radiation Oncology*Biology*Physics. 102: e372-e373. DOI: 10.1016/J.Ijrobp.2018.07.1113 |
0.073 |
|
2022 |
Alymova IV, Cipollo JF, Parsons LM, Music N, Kamal RP, Tzeng WP, Goldsmith CS, Contessa JN, Hartshorn KL, Wilson JR, Zeng H, Gansebom S, York IA. Aberrant Cellular Glycosylation May Increase the Ability of Influenza Viruses to Escape Host Immune Responses through Modification of the Viral Glycome. Mbio. e0298321. PMID 35285699 DOI: 10.1128/mbio.02983-21 |
0.073 |
|
2008 |
Contessa J, Bhojani M, Davis M, Rehemtulla A, Lawrence T. N-linked Glycosylation is a Novel Target for Radiosensitization International Journal of Radiation Oncology*Biology*Physics. 72: S716-S717. DOI: 10.1016/j.ijrobp.2008.06.556 |
0.065 |
|
2019 |
McTyre ER, Soike MH, Farris M, Ayala-Peacock DN, Hepel JT, Page BR, Shen C, Kleinberg L, Contessa JN, Corso C, Chiang V, Henson-Masters A, Cramer CK, Ruiz J, Pasche B, et al. Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 31526671 DOI: 10.1016/J.Radonc.2019.08.011 |
0.059 |
|
2019 |
Hughes RT, Masters AH, McTyre ER, Farris MK, Chung C, Page BR, Kleinberg LR, Hepel J, Contessa JN, Chiang V, Ruiz J, Watabe K, Su J, Fiveash JB, Braunstein S, et al. Initial SRS for patients with 5-15 brain metastases: results of a multi-institutional experience. International Journal of Radiation Oncology, Biology, Physics. PMID 30959122 DOI: 10.1016/J.Ijrobp.2019.03.052 |
0.058 |
|
2017 |
Chen WS, Bindra RS, Mo A, Hayman T, Husain Z, Contessa JN, Yu JB. (S032) Investigating CDKN2A Copy Number Loss in HPV- and HPV+ Head and Neck Cancer: A Demonstration of Integrated Genomic and Clinical Analyses Using TCGA International Journal of Radiation Oncology*Biology*Physics. 98: E10. DOI: 10.1016/J.Ijrobp.2017.02.068 |
0.053 |
|
2015 |
Jairam V, Rutter C, Yu J, Contessa J, Bindra R. Molecular Characteristics and Overall Survival for Grade III Gliomas International Journal of Radiation Oncology*Biology*Physics. 93: E57. DOI: 10.1016/J.Ijrobp.2015.07.687 |
0.05 |
|
2017 |
Muhlestein W, Farris M, McTyre E, Pajewski N, Attia A, Chambless L, Braunstein S, Hepel J, Chung C, Contessa J, Chao S, Fiveash J, Chan M, Ayala-Peacock D. Using a Novel Machine Learning Technique to Predict Brain Metastasis Velocity Following Stereotactic Radiosurgery for Brain Metastases International Journal of Radiation Oncology*Biology*Physics. 99: E96. DOI: 10.1016/J.Ijrobp.2017.06.820 |
0.05 |
|
2017 |
McTyre E, Ayala-Peacock D, Contessa J, Corso C, Chiang V, Chung C, Fiveash J, Ahluwalia M, Kotecha R, Chao S, Attia A, Henson A, Hepel J, Braunstein S, Chan M. Multi-Institutional Competing Risks Analysis of Distant Brain Failure and Salvage Patterns after Upfront Radiosurgery without Whole Brain Radiotherapy for Brain Metastasis. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 29161348 DOI: 10.1093/Annonc/Mdx740 |
0.048 |
|
2017 |
Yeboa D, Yu J, Huse J, Penas-Prado M, Sulman E, Contessa J. RTHP-16. PATTERNS OF TREATMENT AND OUTCOMES OF 1p19q CO-DELETED GLIOMAS Neuro-Oncology. 19: vi222-vi222. DOI: 10.1093/Neuonc/Nox168.900 |
0.04 |
|
2019 |
Yeboa D, Yu J, Liao K, Huse J, Penas-Prado M, Kann B, Sulman E, Grosshans D, Contessa J. OC-0165 Patterns of treatment and outcomes for 1p19q co-deleted gliomas Radiotherapy and Oncology. 133: S80-S81. DOI: 10.1016/S0167-8140(19)30585-7 |
0.038 |
|
2017 |
Henson A, Ayala-Peacock D, Chung C, Hepel J, Chao S, Contessa J, Fiveash J, Attia A, McTyre E, Braunstein S, Page B, Shen C, Kleinberg L, Watabe K, Pasche B, et al. DBF 2.0: A Web-Based Predictive Model for Distant Brain Failure, Brain Metastasis Velocity, and Early Death After Radiosurgery for Brain Metastases International Journal of Radiation Oncology*Biology*Physics. 99: E78-E79. DOI: 10.1016/J.Ijrobp.2017.06.778 |
0.033 |
|
2019 |
Gao S, Kann B, Bindra R, Contessa J, Yu J, Aneja S. Deep Neural Networks for Radiographic Risk Stratification of Gliomas International Journal of Radiation Oncology*Biology*Physics. 105: S121. DOI: 10.1016/J.Ijrobp.2019.06.092 |
0.03 |
|
2018 |
Jairam V, Kann B, Park H, Miccio J, Beckta J, Yu J, Gao S, Prabhu R, Mehta M, Curran W, Bindra R, Contessa J, Patel K. Defining an Intermediate Risk Group for Low Grade Glioma? An Analysis of the National Cancer Database International Journal of Radiation Oncology*Biology*Physics. 102: e249-e250. DOI: 10.1016/J.Ijrobp.2018.07.827 |
0.028 |
|
2019 |
Masters A, Johnson E, Ayala-Peacock D, Chung C, Hepel J, Chao S, Contessa J, Fiveash J, Attia A, McTyre E, Braunstein S, Page B, Kleinberg L, D'Agostino R, Farris M, et al. Predictive Modeling of Brain Metastasis Velocity in a Validated Multi-Institution Cohort International Journal of Radiation Oncology*Biology*Physics. 105: E81. DOI: 10.1016/J.Ijrobp.2019.06.2347 |
0.027 |
|
2013 |
Dosoretz A, Aneja S, Contessa J, Bindra R, Chiang V, Yu J. Long-term Survivors After Treatment of Intracranial Metastases With Radiosurgery International Journal of Radiation Oncology*Biology*Physics. 87: S276. DOI: 10.1016/J.Ijrobp.2013.06.721 |
0.014 |
|
2020 |
Gupte TP, Li C, Jin L, Yalcin K, Youngblood MW, Miyagishima DF, Mishra-Gorur K, Zhao AY, Antonios J, Huttner A, McGuone D, Blondin NA, Contessa JN, Zhang Y, Fulbright RK, et al. Clinical and genomic factors associated with seizures in meningiomas. Journal of Neurosurgery. 1-10. PMID 33276341 DOI: 10.3171/2020.7.JNS201042 |
0.013 |
|
2016 |
Contessa JN, Johung KL, Goldberg S, Chiang VL. Reply to M.S. Copur et al and to M.C. Chamberlain. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27114599 DOI: 10.1200/Jco.2016.67.2816 |
0.01 |
|
Hide low-probability matches. |